{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:49:02Z","timestamp":1790686142952,"version":"4.1.0"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FEDER-UCLM","award":["UCLM 2022"],"award-info":[{"award-number":["UCLM 2022"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Despite the availability of numerous treatments for Crohn disease, there are patients who do not respond to any therapy, thereby diminishing their quality of life. The aim of this review is to analyze the efficacy and safety of autologous hematopoietic stem cell transplantation therapy for refractory Crohn disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This work is a systematic review with meta-analysis conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Review and Meta-Analyses. Electronic databases such as PubMed, Scopus, Web of Science, and ClinicalTrials were consulted. The searches were carried out in August 2024. To evaluate the efficacy of autologous hematopoietic stem cell transplantation in inducing remission, the mean and standard deviation of the Crohn\u2019s Disease Activity Index pre- and post- treatment were used, and a fixed-effects meta-analysis was conducted. Additionally, to assess the efficacy in perianal fistulas, a random-effects meta-analysis was performed, collecting data on the number of subjects with fistulas at the beginning and end of the intervention. All 95% confidence intervals were calculated, and the <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> statistic was used to assess the heterogeneity of the outcome variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 609 records were identified from databases, with 12 studies selected for inclusion in the review. Immediate intervention proved effective in inducing a decrease in the Crohn Disease Activity Index compared to late intervention with conventional therapies. Moreover, the meta-analysis demonstrated efficacy for Crohn disease and associated fistulas with a mean decrease in the CDAI of \u2212217.53\u2005\u00b1\u200514.3. When evaluating the efficacy of the procedure in perianal fistulas, a risk ratio of 0.47 with a 95% CI of [0.26, 0.86] was obtained. However, the procedure showed adverse effects, such as infections, acute renal failure or deaths.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Systemic autologous hematopoietic stem cell transplantation has shown efficacy in patients who fail to achieve remission of their Crohn disease with conventional therapies. This procedure has also demonstrated efficacy in treating perianal fistulas. However, it is essential to carefully evaluate de implementation of this procedure due to the associated risks.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040144","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T18:03:32Z","timestamp":1730138612000},"page":"e40144","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Hematopoietic stem cell transplantation therapy for refractory\u2019 Crohn disease: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5982-259X","authenticated-orcid":false,"given":"Victor","family":"Serrano-Fernandez","sequence":"first","affiliation":[{"name":"Facultad de Fisioterapia y Enfermer\u00eda, Universidad de Castilla-La Mancha, Toledo, Spain"},{"name":"Hospital Universitario de Toledo, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7781-872X","authenticated-orcid":false,"given":"Juan Manuel","family":"Carmona-Torres","sequence":"additional","affiliation":[{"name":"Facultad de Fisioterapia y Enfermer\u00eda, Universidad de Castilla-La Mancha, Toledo, Spain"},{"name":"Grupo de investigaci\u00f3n multidisciplinar en cuidados (IMCU), Universidad de Castilla-La Mancha, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Arroyo-Rodriguez","sequence":"additional","affiliation":[{"name":"Centro Universitario de Enfermer\u00eda \u201cSan Juan de Dios,\u201d Universidad de Sevilla, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Lopez-Gonzalez","sequence":"additional","affiliation":[{"name":"Facultad de Enfermer\u00eda, Universidad de Castilla-La Mancha, Albacete, Spain"},{"name":"Grupo de Actividades Preventivas en el \u00e1mbito Universitario de Ciencias de la Salud (GAP-CS), Universidad de Castilla-La Mancha, Albacete, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseba","family":"Rabanales-Sotos","sequence":"additional","affiliation":[{"name":"Facultad de Enfermer\u00eda, Universidad de Castilla-La Mancha, Albacete, Spain"},{"name":"Grupo de Actividades Preventivas en el \u00e1mbito Universitario de Ciencias de la Salud (GAP-CS), Universidad de Castilla-La Mancha, Albacete, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Alberto","family":"Laredo-Aguilera","sequence":"additional","affiliation":[{"name":"Facultad de Fisioterapia y Enfermer\u00eda, Universidad de Castilla-La Mancha, Toledo, Spain"},{"name":"Grupo de investigaci\u00f3n multidisciplinar en cuidados (IMCU), Universidad de Castilla-La Mancha, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","article-title":"Pathophysiology of Crohn\u2019s disease inflammation and recurrence.","volume":"15","author":"Petagna","year":"2020","journal-title":"Biol Direct"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease.","volume":"12","author":"Seyedian","year":"2019","journal-title":"J Med Life"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.disamonth.2017.07.001","article-title":"A comprehensive review and update on Crohn\u2019s disease.","volume":"64","author":"Gajendran","year":"2018","journal-title":"Dis Mon"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD.","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.sempedsurg.2017.10.003","article-title":"Clinical presentation of Crohn\u2019s, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes.","volume":"26","author":"Yu","year":"2017","journal-title":"Semin Pediatr Surg"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.14309\/ajg.0000000000002326","article-title":"Management of perianal Crohn\u2019s disease.","volume":"118","author":"Parian","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.cgh.2018.01.030","article-title":"Efficacy of medical therapies for fistulizing Crohn\u2019s disease: systematic review and meta-analysis.","volume":"16","author":"Lee","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ecco-jcc\/jjz187","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: surgical treatment.","volume":"14","author":"Adamina","year":"2020","journal-title":"J Crohns Colitis"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management.","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00535-022-01903-6","article-title":"Renal manifestations in inflammatory bowel disease: a systematic review.","volume":"57","author":"van Hoeve","year":"2022","journal-title":"J Gastroenterol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"030006052210988","DOI":"10.1177\/03000605221098868","article-title":"Evaluation of health-related quality of life and influencing factors in patients with Crohn disease.","volume":"50","author":"Gao","year":"2022","journal-title":"J Int Med Res"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment.","volume":"14","author":"Torres","year":"2020","journal-title":"J Crohns Colitis"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"105075","DOI":"10.1016\/j.phrs.2020.105075","article-title":"Inflammatory bowel disease \u2013 non-biological treatment.","volume":"160","author":"Magro","year":"2020","journal-title":"Pharmacol Res"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management.","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R16-20250503","first-page":"CD008870","article-title":"Aminosalicylates for induction of remission or response in Crohn\u2019s disease.","volume":"2016","author":"Lim","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.gtc.2017.05.015","article-title":"Janus kinase antagonists and other novel small molecules for the treatment of Crohn\u2019s disease.","volume":"46","author":"Boland","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00384-021-03857-2","article-title":"Surgical management of Crohn\u2019s disease: a state of the art review.","volume":"36","author":"Meima -Van Praag","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/medicina58050567","article-title":"Inflammatory bowel disease: clinical diagnosis and surgical treatment-overview.","volume":"58","author":"M\u2019koma","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-med-070119-115617","article-title":"Hematopoietic stem cell transplantation for autoimmune disease.","volume":"72","author":"Alexander","year":"2020","journal-title":"Annu Rev Med"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.3390\/nu15143114","article-title":"High-fiber diet and Crohn\u2019s disease: systematic review and meta-analysis.","volume":"15","author":"Serrano Fernandez","year":"2023","journal-title":"Nutrients"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gastrohep.2018.08.004","article-title":"Trasplante de precursores hematopoy\u00e9ticos en enfermedad de Crohn refractaria: experiencia en nuestro centro.","volume":"42","author":"Hernanz","year":"2019","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3747\/co.26.5033","article-title":"A general practitioner\u2019s guide to hematopoietic stem-cell transplantation.","volume":"26","author":"Bazinet","year":"2019","journal-title":"Curr Oncol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4252\/wjsc.v12.i10.1113","article-title":"Medical, ethical, and legal aspects of hematopoietic stem cell transplantation for Crohn\u2019s disease in Brazil.","volume":"12","author":"Ruiz","year":"2020","journal-title":"World J Stem Cells"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri1779","article-title":"Bone-marrow haematopoietic-stem-cell niches.","volume":"6","author":"Wilson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.3390\/cells10123433","article-title":"Adipose tissue-derived mesenchymal stem cells.","volume":"10","author":"Bunnell","year":"2021","journal-title":"Cells"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ecco-jcc\/jjx184","article-title":"Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn\u2019s disease: a review on behalf of ECCO and EBMT.","volume":"12","author":"Snowden","year":"2018","journal-title":"J Crohns Colitis"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"8494","DOI":"10.3390\/ijms23158494","article-title":"Stem cell-based therapies for inflammatory bowel disease.","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/s41375-020-01062-8","article-title":"Hematopoietic stem and progenitor cell signaling in the niche.","volume":"34","author":"Hurwitz","year":"2020","journal-title":"Leukemia"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/cells8080784","article-title":"Mesenchymal stem cell migration and tissue repair.","volume":"8","author":"Fu","year":"2019","journal-title":"Cells"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial.","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12968\/hmed.2019.80.1.33","article-title":"Haematopoietic stem cell transplants: principles and indications.","volume":"80","author":"Balassa","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bjh.18311","article-title":"Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.","volume":"198","author":"Sharma","year":"2022","journal-title":"Br J Haematol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1002\/sctm.20-0481","article-title":"Optimizing allogeneic grafts in hematopoietic stem cell transplantation.","volume":"10","author":"Xu","year":"2021","journal-title":"Stem Cells Transl. Med"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s13287-021-02533-0","article-title":"Stem cell therapy for Crohn\u2019s disease: systematic review and meta-analysis of preclinical and clinical studies.","volume":"12","author":"Wang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13287-017-0570-x","article-title":"Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn\u2019s disease.","volume":"8","author":"Qiu","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003\u20132007 versus 2013\u20132017 cohorts.","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"e015201","DOI":"10.1136\/bmjopen-2016-015201","article-title":"Living with Crohn\u2019s disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study).","volume":"7","author":"Cooper","year":"2017","journal-title":"BMJ Open"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2004.11.051","article-title":"Autologous hematopoietic stem cell transplantation in patients with refractory Crohn\u2019s disease.","volume":"128","author":"Oyama","year":"2005","journal-title":"Gastroenterology"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.2015.16700","article-title":"Autologous hematopoetic stem cell transplantation for refractory Crohn disease: a randomized clinical trial.","volume":"314","author":"Hawkey","year":"2015","journal-title":"JAMA"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R44-20250503","article-title":"Risk Of Bias In Non-randomized Studies - of Exposure (ROBINS-E). Launch version.","author":"Higgins","year":"2023"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study.","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD.","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/ecco-jcc\/jjx054","article-title":"Autologous haematopoietic stem cell transplantation for refractory Crohn\u2019s disease: efficacy in a single-centre cohort.","volume":"11","author":"L\u00f3pez-Garc\u00eda","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/gutjnl-2015-309836","article-title":"Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn\u2019s disease.","volume":"65","author":"Jauregui-Amezaga","year":"2016","journal-title":"Gut"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/apt.12032","article-title":"Remission of refractory Crohn\u2019s disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation.","volume":"36","author":"Hasselblatt","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13104-017-2824-1","article-title":"Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn\u2019s disease.","volume":"10","author":"Ruiz","year":"2017","journal-title":"BMC Res Notes"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ecco-jcc\/jjx180.020","article-title":"Autologous haematopoietic stem cell transplantation for Crohn\u2019s disease: a retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation.","volume":"12","author":"Brierley","year":"2018","journal-title":"J Crohns Colitis"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/gut.2007.128694","article-title":"Autologous haematopoietic stem cell transplantation without CD34 + cell selection in refractory Crohn\u2019s disease.","volume":"57","author":"Cassinotti","year":"2008","journal-title":"Gut"},{"issue":"Supplement_1","key":"R53-20250503","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1093\/ecco-jcc\/jjy222.521","article-title":"P397 Autologous stem cell transplantation in refractory Crohn\u2019s disease: evaluation of a modified mobilisation regimen and analyses of the cost-effectiveness.","volume":"13","author":"Mahmmod","year":"2019","journal-title":"J Crohns Colitis"},{"key":"R54-20250503","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1182\/blood-2010-06-292391","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up.","volume":"116","author":"Burt","year":"2010","journal-title":"Blood"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S2468-1253(23)00460-0","article-title":"Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn\u2019s disease (ASTIClite): an open-label, multicentre, randomised controlled trial.","volume":"9","author":"Lindsay","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","article-title":"Articles Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I\/II study.","volume":"8","author":"Burt","year":"2009","journal-title":"Lancet Neurol"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/1352458510364538","article-title":"High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience.","volume":"16","author":"Krasulov\u00e1","year":"2010","journal-title":"Mult Scler"},{"key":"R58-20250503","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term followup of a prospective clinical trial.","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(17)30056-0","article-title":"Autologous stem-cell transplantation in treatment-refractory Crohn\u2019s disease: an analysis of pooled data from the ASTIC trial.","volume":"2","author":"Lindsay","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/qjmed\/hcu095","article-title":"Autologous stem cell transplantation in severe treatment-resistant Crohn\u2019s disease: long-term follow-up of UK patients treated on compassionate basis.","volume":"107","author":"Snowden","year":"2014","journal-title":"QJM"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/s41409-020-0953-y","article-title":"A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease.","volume":"55","author":"Burt","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"R62-20250503","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1038\/s41598-017-04984-z","article-title":"Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn\u2019s disease complicated with inflammatory mass.","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"R63-20250503","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/1751-7915.13536","article-title":"Efficacy of faecal microbiota transplantation in Crohn\u2019s disease: a new target treatment?","volume":"13","author":"Xiang","year":"2020","journal-title":"Microb Biotechnol"},{"key":"R64-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease.","volume":"11","author":"Nishida","year":"2018","journal-title":"Clin J Gastroenterol"},{"key":"R65-20250503","doi-asserted-by":"crossref","first-page":"e00213","DOI":"10.14309\/ctg.0000000000000213","article-title":"Host genetic and gut microbial signatures in familial inflammatory bowel disease.","volume":"11","author":"Park","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"R66-20250503","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.gtc.2017.08.005","article-title":"Fecal transplant in inflammatory bowel disease.","volume":"46","author":"Browne","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"R67-20250503","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40168-020-0792-5","article-title":"Fecal microbiota transplantation to maintain remission in Crohn\u2019s disease: a pilot randomized controlled study.","volume":"8","author":"Sokol","year":"2020","journal-title":"Microbiome"},{"key":"R68-20250503","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10620-019-05751-y","article-title":"Fecal microbiota transplant via endoscopic delivering through small intestine and colon: no difference for Crohn\u2019s disease.","volume":"65","author":"Yang","year":"2020","journal-title":"Dig Dis Sci"},{"key":"R69-20250503","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ibd\/izz215","article-title":"Matrix-delivered autologous mesenchymal stem cell therapy for refractory rectovaginal Crohn\u2019s fistulas.","volume":"26","author":"Lightner","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"R70-20250503","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5009\/gnl17035","article-title":"Umbilical cord mesenchymal stem cell treatment for Crohn\u2019s disease: a randomized controlled clinical trial.","volume":"12","author":"Zhang","year":"2018","journal-title":"Gut Liver"},{"key":"R71-20250503","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13287-023-03331-6","article-title":"Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials.","volume":"14","author":"Wang","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"R72-20250503","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10151-019-02024-8","article-title":"Mesenchymal stem-cell therapy for perianal fistulas in Crohn\u2019s disease: a systematic review and meta-analysis.","volume":"23","author":"Cheng","year":"2019","journal-title":"Tech Coloproctol"},{"key":"R73-20250503","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/biom11010082","article-title":"Efficacy and safety of mesenchymal stem\/stromal cell therapy for inflammatory bowel diseases: an up-to-date systematic review.","volume":"11","author":"Ko","year":"2021","journal-title":"Biomolecules"},{"key":"R74-20250503","doi-asserted-by":"crossref","first-page":"23259671211058459","DOI":"10.1177\/23259671211058459","article-title":"High variability of mesenchymal stem cells obtained via bone marrow aspirate concentrate compared with traditional bone marrow aspiration technique.","volume":"9","author":"Brozovich","year":"2021","journal-title":"Orthop J Sports Med"},{"key":"R75-20250503","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/ecco-jcc\/jjab112","article-title":"ECCO topical review: refractory inflammatory bowel disease.","volume":"15","author":"Raine","year":"2021","journal-title":"J Crohns Colitis"},{"key":"R76-20250503","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot.","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:17:26Z","timestamp":1746317846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":76,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040144","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}